Menu
about-us-banner
Notch Left
Notch Right

LEADING API manufacturER

Harman Finochem Limited is a leading India-based Pharmaceutical Company which specializes in the manufacture and export of more than 45 Active Pharmaceutical Ingredients (APls) of which 10 are Essential Drugs as per the WHO Model List.

We deliver top quality products to more than 35 countries across the globe.

Management Team

Mr. Bhupinder Singh Manhas

Chairman and Managing Director

Mr. Harpreet Singh Minhas

Director

Dr. Gurpreet Singh Minhas

Director

The founder of Harman Finochem and a dedicated pharma professional since past 30 years. Under his guidance and support the company has achieved magnificent milestones. He continues to play a key role as Chairman of Guru Nanak Hospital, Mumbai.

Mr. Manhas earned a Master’s degree in Science.

Mr Minhas has extensive industrial experience in the pharmaceutical industry and personally led various departments of Harman Finochem. A man with a vision par excellence. He heads HR, Business Development, Operations and Projects.

Mr. Minhas is a Science graduate with a Master’s degree in Finance.

With a dynamic approach towards Marketing and Product development, he who travels extensively across the globe, exploring opportunities for innovation and growth. He ably leads the Marketing, Purchase, Regulatory and R&D teams.

Dr. Minhas holds a Doctorate in Pharmaceutical Chemistry.

QUALITY IS OF PARAMOUNT IMPORTANCE

Harman Finochem ensures that its customers worldwide are delighted by receiving APl’s which are safe, efficient and of highest quality. We adhere to principles of cGmp and our team at all levels is committed to achieving this corporate excellence goal.

World Class Facilities

Vision and Value

Acquire Prominence in global market in the field of APIs

CERTIFICATIONS & ACCREDITIONS

Harman Finochem is accredited by various regulatory authorities like the Certificate of Suitability (COS) from European Directorate of Quality Medicines (EDQM), Pharmaceutical Inspection Convention (PIC) members countires, TGA-Australia, HPB Canada, Japanese Ministry of Health & Labour Welfare, etc. Harman Finochem is also recognised as an ‘Export House’ by Ministry of Commerce, Government of India.

We have various DMF and CEP approvals

DMF approvals list PDFCEP approvals list PDF

Major Milestones

  • 1983
    • Inception of Harman
      Finochem Limited
    • Inception of Harman Finochem Limited

    • Paracetamol Commercial Production Started


    • Riboflavin Phosphate Sodium Commercial Production Started

    • Metformin Hydrochloride Commercial Production Started


    • Received Certificate of Suitability
      from EDQM for the product Metformin HCl


    • Received Certificate of Suitability
      from EDQM for the product Allopurinol

    • Received Generic Companies
      in USA, EU and Canada Site I
    • Aurangabad USFDA inspected


    • Received Certificate of Suitability
      from EDQM for the product Phenobarbital


    • Accreditation of Health Canada, Korean FDA, WHO- GMP, Japanese health authorities
    • Japanese accreditation for Site I – Aurangabad


    • German Health Authorities Japanese accreditation accreditation for Site I- Aurangabad
    • Site II-Aurangabad USFDA inspected


    • TGA Approval
    • Site I and Site II, Both inspected by USFDA, no 483s issued
    • Received Certificate of Suitability from EDQM for the product Ketamine


    • Received Certificate of Suitability from EDQM for the product
      Fenofibrate
    • Certificate of Suitability issued Received from EDQM for the product Oxybutynin


    • Site II –Aurangabad
      Korean FDA
      inspected


    • Site I-Auranganbad USFDA inspected, no 483s issued Site II-Auranganbad
    • USFDA inspected, no 483s issued


    • German Health Authorities inspection for Site I & Site II – Aurangabad
    • Received Certificate of Suitability from EDQM for the product Glycopyrrolate
    • Received Certificate of Suitability from EDQM for the product
      Methadone HCl
    • Received Certificate of Suitability from EDQM for the product
      Riboflavin Sodium phosphate

    • Cofepris inspection for Shendra – Aurangabad site for
      Divalproex Sodium

    • Site I and Site II, Both inspected by
      USFDA